Recombinant Human PLA2G16 (N-6His)

Description

EnkiLife provides the Recombinant Human PLA2G16 (N-6His) protein,aslo know as Group XVI Phospholipase A1/A2,Adipose-Specific Phospholipase A2,AdPLA,H-Rev 107 Protein Homolog,HRAS-Like Suppressor 1,HRAS-Like Suppressor 3,HRSL3,HREV107-1,HREV107-3,Renal Carcinoma Antigen NY-REN-65,PLA2G16,HRASLS3,HREV107, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Phospholipase A2 Group XVI is produced by our E.coli expression system and the target gene encoding Asp12-Asp132 is expressed with a 6His tag at the N-terminus.Accession:P53816. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:14-17 KDa. Background:Group XVI Phospholipase A1/A2 (PLA2G16) belongs to the H-rev 107 family. PLA2G16 is expressed in a number of human tumors including ovarian carcinomas, lung carcinomas. PLA2G16 is involved in the regulation of differentiation and survival. PLA2G16 regulates adipocyte lipolysis and release of fatty acids through a G-protein coupled pathway involving prostaglandin and EP3. It has also been reported to play a crucial role in the development of obesity in mouse models.